Navistar International Corporation - Business Snapshot & SWOT Analysis - Q1 2011

Noealt Corporate Services
February 1, 2011
150 Pages - SKU: NOLS6278590
Nuvo Research Inc. - Product Pipeline Review - 2014
11/30/2014 | published by: Global Markets Direct
Nuvo Research Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Nuvo Research Inc. - Product Pipeline Review - 2014’, provides an overview of the Nuvo Research Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Transportation-Warehousing: State Industry Market Evaluator 48
12/1/2014 | published by: BizMiner
Transportation-Warehousing: State Industry Market Evaluator 48 This State Industry Market Evaluator reports on industry trends broken out for each US state. Each state sub-report is comprised of eight pages of data. Statistics are displayed for 2011-2012-2013-2014q2  |  read more...
USD 599
NovaBay Pharmaceuticals, Inc. - Product Pipeline Review - 2014
12/10/2014 | published by: Global Markets Direct
NovaBay Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘NovaBay Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the NovaBay Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
NeoStem, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
NeoStem, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘NeoStem, Inc. - Product Pipeline Review - 2014’, provides an overview of the NeoStem, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Novogen Limited - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
Novogen Limited - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Novogen Limited - Product Pipeline Review - 2014’, provides an overview of the Novogen Limited’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Neurotez, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
Neurotez, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Neurotez, Inc. - Product Pipeline Review - 2014’, provides an overview of the Neurotez, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
NovoBiotic Pharmaceuticals, LLC - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
NovoBiotic Pharmaceuticals, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘NovoBiotic Pharmaceuticals, LLC - Product Pipeline Review - 2014’, provides an overview of the NovoBiotic Pharmaceuticals, LLC’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Nuevolution A/S - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
Nuevolution A/S - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Nuevolution A/S - Product Pipeline Review - 2014’, provides an overview of the Nuevolution A/S’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
NetApp Inc (NTAP: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/10/2014 | published by: Plunkett Research, Ltd.
NetApp Inc (NTAP: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (NetApp Inc, NTAP: NAS) compared to its top competitors  |  read more...
USD 1,795
NuVasive Inc (NUVA: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/6/2014 | published by: Plunkett Research, Ltd.
NuVasive Inc (NUVA: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (NuVasive Inc, NUVA: NAS) compared to its top competitors  |  read more...
USD 1,795
 

SELECT A LICENSE

    Online Download  USD 150  
    Global Site License  USD 395  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!